Your browser doesn't support javascript.
Origin and evolutionary analysis of the SARS-CoV-2 Omicron variant.
Sun, Yamin; Lin, Wenchao; Dong, Wei; Xu, Jianguo.
  • Sun Y; Research Institute of Public Health, Nankai University, Tianjin, PR China.
  • Lin W; Engineering and Research Center for Microbial Functional Genomics and Detection Technology, Ministry of Education, Nankai University.
  • Dong W; Engineering and Research Center for Microbial Functional Genomics and Detection Technology, Ministry of Education, Nankai University.
  • Xu J; Engineering and Research Center for Microbial Functional Genomics and Detection Technology, Ministry of Education, Nankai University.
J Biosaf Biosecur ; 4(1): 33-37, 2022 Jun.
Article in English | MEDLINE | ID: covidwho-1587192
ABSTRACT
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has evolved rapidly into new variants throughout the pandemic. The Omicron variant has more than 50 mutations when compared with the original wild-type strain and has been identified globally in numerous countries. In this report, we analyzed the mutational profiles of several variants, including the per-site mutation rate, to determine evolutionary relationships. The Omicron variant was found to have a unique mutation profile when compared with that of other SARS-CoV-2 variants, containing mutations that are rare in clinical samples. Moreover, the presence of five mouse-adapted mutation sites suggests that Omicron may have evolved in a mouse host. Mutations in the Omicron receptor-binding domain (RBD) region, in particular, have potential implications for the ongoing pandemic.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study Topics: Variants Language: English Journal: J Biosaf Biosecur Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study Topics: Variants Language: English Journal: J Biosaf Biosecur Year: 2022 Document Type: Article